Healthcare and Life Science
Biodesix announces expanded Bio-Rad Laboratories partnership agreement to develop Droplet Digital™ PCR High Complexity Assays
Biodesix will perform the clinical validation of ddPLEX ESR1 Mutation Detection Assay for advanced breast cancer testing ...
ProImmune expands into new 18,000 sq ft global headquarters enabling major expansion in immunology and life science innovation
Move follows ProImmune’s recent acquisition of Oasis Park a 70,000 sq ft Business and Light Industrial Park in Oxford, UKIncreased operational capacity enables accelerated development of ProImmune’s REVEAL® Immunogenicity System and Ankyron® target binding technologiesOxford, UK, 22 Oct...
Bio-Rad’s iQ-Check Enterobacteriaceae Kit validated for detection of Enterobacteriaceae in infant formula and cereals
Certified by MicroVal for Detection of Enterobacteriaceae Including Salmonella, Cronobacter, and E.coli as Indicator of Process Effectiveness to Eliminate Contaminants in Infant Formula and Related Ingredients. ...
Enamine contributes to the discovery of promising broad-spectrum coronavirus antiviral
Open-science research initiative, COVID Moonshot and the AI-driven Structure-enabled Antiviral Platform (ASAP) consortium, delivered a promising pre-clinical candidate2,000 new compounds generated for the programme are now available from Enamine’s catalogueKyiv, Ukraine, 21 October, 202...
Mosaic Therapeutics appoints Thomas Fuchs as CEO
Former CEO of Cimeio Therapeutics, and Global Haematology Franchise Head at Roche-Genentech, brings extensive track record of strategic and operational leadershipAppointment strengthens executive leadership team and supports transition into clinical developmentCambridge, UK, 20 October ...
giles introduces AI agent to accelerate healthcare and life science research
AI tool connects researchers to verified medical and life sciences global databases, enabling accurate extraction and summarisation of academic papers, journals, and articlesgiles will be showcased at ISPOR Europe 2025, Glasgow, 9-12th November, booth 314London, UK, 20 October 2025: gil...
TTP improves Bluetooth connectivity for implantable continuous glucose monitors
TTP’s Biosensing team has tackled one of the biggest challenges in implantable continuous glucose monitors: achieving reliable Bluetooth® Low Energy (BLE) connectivity within extreme size and power constraints. By taking a system-level approach that integrates RF design, antenna miniatu...
Cyclana Bio raises £5M to advance drug discovery for Endometriosis
Co-led by NfX and Eka VC, investors include Cocoa VC, Wilbe, and Angel investorsInvestment will support development of whole tissue-based platform for identification of druggable targets and scaling of observational clinical trialCambridge, UK, 20th October 2025 – Cyclana Bio, a bi...
Population health in respiratory care: From data to actionable insights
In an era where healthcare systems face mounting pressures from chronic disease burdens, population health has emerged as a strategic framework to improve outcomes across communities rather than focusing solely on individual patients. Respiratory diseases, in particular chronic obstruct...
TTP Plc extends ISO 13485 certification to contract manufacture of medical devices and IVDs
TTP plc has expanded its ISO 13485 certification to include the contract manufacture of medical devices and in vitro diagnostics, covering implantable and active implantable devices. This extension builds on TTP’s 15-year track record in ISO-certified medical device development and rein...